Trial Profile
A study evaluating association between serum golimumab trough levels, clinical disease activity and treatment response in patients with axial spondyloarthritis.
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Oct 2017
Price :
$35
*
At a glance
- Drugs Golimumab (Primary)
- Indications Ankylosing spondylitis
- Focus Pharmacokinetics; Therapeutic Use
- 13 Oct 2017 New trial record
- 15 Sep 2017 Results published in the Clinical and Experimental Rheumatology